Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Mol Cancer Ther. 2014 Dec 17;14(2):513–522. doi: 10.1158/1535-7163.MCT-14-0208

Figure 5. Response to sunitinib dose-escalation in patients with clear cell renal cell carcinoma.

Figure 5

Two patients with ccRCC who were initially responsive to 50 mg of sunitinib eventually became resistance. Increased dose of 75mg restored response to sunitinib. A) and B) representative CT images from two patients and arrows indicate tumor lesions.